Substantial Improvement in UK Cervical Cancer Survival with Chemoradiotherapy: Results of a Royal College of Radiologists' Audit

Clinical Oncology

Volumn 22, Issue 7, 2010, Pages 590-601

  Vale, C L ^a   Tierney, J F ^a   Davidson, S E ^b   Drinkwater, K J ^c   Symonds, P ^d  

^a MRC CLINICAL TRIALS UNIT   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

^c ROYAL COLLEGE OF RADIOLOGISTS   (United Kingdom)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Audit; Cervical cancer; Chemoradiotherapy

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CISPLATIN; FLUOROURACIL; METHOTREXATE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLADDER DISEASE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COLORECTAL DISEASE; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDICAL AUDIT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; UNITED KINGDOM; UTERINE CERVIX CANCER; VAGINA DISEASE;

EID: 77955653446     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2010.06.002     Document Type: Article

References (18)

1. Cancer Research UK UK cervical cancer incidence statistics 2009.
2. Quinn M.J., Babb P., Jones J., Allen E. Effect of screening on incidence of and mortality from cervix cancer in England: evaluation based on routinely collected statistics. Br Med J 1999, 318:904-908.
3. Schrijivers C.T.M., Mackenbach J.P., Lutz J.M., Quinn M.J., Coleman M.P. Deprivation, stage at diagnosis and cancer survival. Int J Cancer 1995, 63:324-329.
4. National Cancer Institute. NCI issues clinical announcement on cervical cancer: chemotherapy plus radiation improves survival 1999, 99.
5. Rose P.G., Bundy B.N., Watkins E.B., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. New Engl J Med 1999, 340:1144-1153.
6. Whitney C.W., Sause W., Bundy B.N., et al. Randomised comparison of fluorouracil plus cisplatin versus hydroxyurea in stage IIB/IVA in carcinoma of the cervix. J Clin Oncol 1999, 17:1339-1348.
7. Keys H.M., Bundy B.N., Stehman F.B., et al. Cisplatin, radiation and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. New Engl J Med 1999, 340:1154-1161.
8. Morris M., Eifel P.J., Lu J., et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. New Engl J Med 1999, 340:1137-1143.
9. Peters W.A., Liu P.Y., Barrett R.G.W., et al. Cisplatin, 5-fluorouracil plus radiation therapy are superior to radiation therapy as adjunctive therapy in high risk, early stage carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: report of a phase III inter group study. Gynecol Oncol 1999, 72(3):443.
10. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 2008, 26(35):5802-5812. Chemoradiotherapy for Cervical Cancer Meta-analysis Collaboration.
11. Tan L.T., Zahra M. Long-term survival and late toxicity after chemo-radiotherapy for cervical cancer - the Addenbrooke's experience. Clin Oncol 2008, 20:358-364.
12. Spensley S., Hunter R.D., Livsey J.E., Swindell R., Davidson S.E. Clinical outcome for chemoradiotherapy in carcinoma of the cervix. Clin Oncol 2009, 21(1):49-55.
13. Goonatillake S., Khong R., Hoskin P. Chemoradiation in gynaecological cancer. Clin Oncol 2009, 21(7):566-572.
14. Chassagne D., Sismondi P., Horiot J.C., et al. A glossary for reporting complications of treatment in gynecological cancers. Radiother Oncol 1993, 26:195-202.
15. Denton A.S., Bond S.J., Matthews S.J., Bentzen S.M., Maher E.J. National audit of the management and outcomes of carcinoma of the cervix treated with radiotherapy in 1993. Clin Oncol 2000, 12:347-353. UK Link Gynaecology-Oncology Group.
16. Quinn M., Benedet J., Odicino F., et al. Carcinoma of the cervix uteri. FIGO 6th annual report on the results of treatment in gynaecological cancer. Int J Gynaecol Obstet 2006, 95(Suppl. 1):S43-S103.
17. Davidson S.E., Burns M.P., Routledge J.A., Swindell R., Bentzen S.M., West C.M.L. Assessment of morbidity in carcinoma of the cervix: a comparison of the LENT SOMA scales and the Franco-Italian glossary. Radiother Oncol 2003, 69:195-200.
18. Davidson S.E., Trotti A., Ataman O.U., et al. Improving the capture of adverse event data in clinical trials: the role of the International Atomic Energy Agency. Int J Radiat Oncol Biol Phys 2007, 69:1218-1221.